| 1,993 | 16 | 306 |
| 下载次数 | 被引频次 | 阅读次数 |
非洲猪瘟(African swine fever,ASF)是由非洲猪瘟病毒(African swine fever virus,ASFV)引起的以钝缘蜱为传播媒介的急性、热性、高度接触性传染病,可感染各品种和各年龄段的家猪及野猪,死亡率可达100%。2018年8月3日中国发生首例非洲猪瘟疫情。由于非洲猪瘟病毒基因组十分庞大,免疫逃逸机制十分复杂,以及现阶段对非洲猪瘟病毒保护性免疫知之甚少,导致迄今为止仍无有效疫苗问世。近年来,随着现代生物学的发展,非洲猪瘟疫苗研发取得了较大的进展,本文对现有的非洲猪瘟疫苗研究进展进行综述,以期为中国非洲猪瘟疫苗的研发提供参考。
Abstract：African swine fever(ASF)is an acute and highly contagious disease caused by the African swine fever virus(ASFV). Ornithodoros species are the vectors of the ASFV. Ornithodoros species can infect domestic pigs and wild pigs of all ages,and the mortality rate is up to 100%. On 3 August 2018,the first ASF epidemic in China was documented. The mechanism by which the ASFV evades the immune system of the host is very complex. Also,little is known about protective immunity against the ASFV. Hence,an efficacious vaccine to counteract the ASFV has not been developed. Nevertheless,in recent years,research and development into a vaccine against ASF has made considerable progress,which we summarize here. We hope that our summary can be a reference for the research and development of a vaccine against ASF in China.
[1]Galindo I,Alonso C.African swine fever virus:a review[J].Viruses,2017,9(5):103.
[2]Anderson E C,Hutchings G H,Mukarati N,Wilkinson P J.African swine fever virus infection of the bushpig(Potamochoerus porcus)and its significance in the epidemiology of the disease[J].Vet Microbiol,1998,62(1):1-15.
[3]Malogolovkin A,Burmakina G,Titov I,Sereda A,Gogin A,Baryshnikova E,Kolbasov D.Comparative analysis of African swine fever virus genotypes and serogroups[J].Emerging Infect Dis,2015,21(2):312-315.
[4]Dixon L K,Chapman D A G,Netherton C L,Upton C.African swine fever virus replication and genomics[J].Virus Res,2013,173(1):3-14.
[5]Salas M L.African swine fever virus(Asfarviridae)[M].Encyclopedia of Virology,1999.
[6]Montgomery E R.On a form of swine fever occurring in British East Africa(Kenya Colony)[J].J Comp Pathol Ther,1921,34:159-191.
[7]Mur L,Igolkin A,Varentsova A,Pershin A,Remyga S,Shevchenko I,Zhukov I,Sánchez-Vizcaíno J M.Detection of African swine fever antibodies in experimental and field samples from the Russian federation:implications for control[J/OL].Transboundary Emerging Dis,2016,63(5):e436-40.
[8]Ge S,Li J,Fan X,Liu F,Li L,Wang Q,Ren W,Bao J,Liu C,Wang H,Liu Y,Zhang Y,Xu T,Wu X,Wang Z.Molecular characterization of African swine fever virus,China,2018[J].Emerg Infect Dis,2018,24(11):2131-2133.
[9]Dixon L K,Abrams C C,Bowick G,Goatley L C,Kay-Jackson P C,Chapman D,Liverani E,Nix R,Silk R,Zhang F.African swine fever virus proteins involved in evading host defence systems[J].Vet Immunol Immunopathol,2004,100(3-4):117-134.
[10]Rock D L.Challenges for African swine fever vaccine development-“…perhaps the end of the beginning.”[J].Vet Microbiol,2017,206:52-58.
[11]Stone S S,Hess W R.Antibody response to inactivated preparations of African swine fever virus in pigs[J].Am J Vet Res,1967,28(123):475-481.
[12]Forman A J,Wardley R C,Wilkinson P J.The immunological response of pigs and Guinea pigs to antigens of African swine fever virus[J].Arch Virol,1982,74(2-3):91-100.
[13]Kihm U,Ackermann M,Mueller H,Pool R.Approaches to vaccination[M].African Swine Fever.Springer US,1987.
[14]Blome S,Gabriel C,Beer M.Modern adjuvants do not enhance the efficacy of an inactivated African swine fever virus vaccine preparation[J].Vaccine,2014,32(31):3879-3882.
[15]Borca M V,Irusta P,Carrillo C,Afonso C L,Burrage T,Rock D L.African swine fever virus structural protein p72 contains a conformational neutralizing epitope[J].Virology,1994,201(2):413-418.
[16]Tlaxca,JoséL,Ellis S,Remmele R L.Live attenuated and inactivated viral vaccine formulation and nasal delivery:Potential and challenges[J].Adv Drug Delivery Rev,2015,93:56-78
[17]Leit?o A,Cartaxeiro C,Coelho R,Cruz B,Parkhouse R M,Portugal F,Vigário J D,Martins C L.The nonhaemadsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response[J].J Gen Virol,2001,82(3):513-523.
[18]Gallardo C,Sánchez EG,Pérez-Nú?ez D,Nogal M,de León P,CarrascosaáL,Nieto R,Soler A,Arias ML,Revilla Y.African swine fever virus(ASFV)protection mediated by NH/P68 and NH/P68 recombinant live-attenuated viruses[J].Vaccine,2018,36(19):2694-2704.
[19]King K,Chapman D,Argilaguet J M,Fishbourne E,Hutet E,Cariolet R,Hutchings G,Oura C A,Netherton C L,Moffat K,Taylor G,Le Potier M F,Dixon LK,Takamatsu H H.Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunisation[J].Vaccine,2011,29(28):4593-4600.
[20]Mulumba-Mfumu L K,Goatley L C,Saegerman C,Takamatsu H H,Dixon L K.Immunization of African Indigenous pigs with attenuated genotype I African swine fever virus OURT88/3 induces protection against challenge with virulent strains of genotype I[J/OL].Transboundary Emerging Dis,2016,63(5):e323-7.
[21]Sánchez-Cordón,Pedro J,Chapman D,Jabbar T,Reis A L,Goatley L,Netherton C L,Taylor G,Montoya M,Dixon L.Different routes and doses influence protection in pigs immunised with the naturally attenuated African swine fever virus isolate OURT88/3[J].Antiviral Res,2017,138:1-8.
[22]Tabarés E,Olivares I,Santurde G,Garcia M J,Martin E,Carnero M E.African swine fever virus DNA:deletions and additions during adaptation to growth in monkey kidney cells[J].Arch Virol,1987,97(3-4):333-346.
[23]Krug P W,Holinka L G,O′Donnell V,Reese B,Sanford B,Fernandez-Sainz I,Gladue D P,Arzt J,Rodriguez L,Risatti G R,Borca M V.The progressive adaptation of a georgian isolate of African swine fever virus to vero cells leads to a gradual attenuation of virulence in swine corresponding to major modifications of the viral genome[J].J Virol,2014,89(4):2324-2332.
[24]Moore D M,Zsak L,Neilan J G,Lu Z,Rock D L.The African swine fever virus thymidine kinase gene is required for efficient replication in swine macrophages and for virulence in swine[J].J Virol,1998,72(12):10310-10315.
[25]Lewis T,Zsak L,Burrage T G,Lu Z,Kutish G F,Neilan J G,Rock D L.An African swine fever virus ERV1-ALR homologue,9GL,affects virion maturation and viral growth in macrophages and viral virulence in swine[J].J Virol,2000,74(3):1275-1285.
[26]O′Donnell V,Holinka L G,Krug P W,Gladue D P,Carlson J,Sanford B,Alfano M,Kramer E,Lu Z,Arzt J,Reese B,Carrillo C,Risatti G R,Borca M V.African swine fever virus Georgia 2007 with a deletion of virulence-associated gene 9GL(B119L),when administered at low doses,leads to virus attenuation in swine and induces an effective protection against homologous challenge[J].J Virol,2015,89(16):8556-8566.
[27]O′Donnell V,Holinka L G,Gladue D P,Sanford B,Krug P W,Lu X,Arzt J,Reese B,Carrillo C,Risatti G R,Borca M V.African swine fever virus Georgia isolate harboring deletions of MGF360 and MGF505 genes is attenuated in swine and confers protection against challenge with virulent parental virus[J].J Virol,2015,89(11):6048-6056.
[28]O"Donnell V,Risatti G R,Holinka L G,Krug P W,Carlson J,Velazquez-Salinas L,Azzinaro P A,Gladue D P,Borca M V.Simultaneous deletion of the 9GL and UK genes from the African swine fever virus Georgia2007 isolate offers increased safety and protection against homologous challenge[J/OL].J Virol,2016,91(1):e01760-16.
[29]Abrams C C,Goatley L,Fishbourne E,Chapman D,Cooke L,Oura C A,Netherton C L,Takamatsu H H,Dixon L K.Deletion of virulence associated genes from attenuated African swine fever virus isolate OUR T88/3decreases its ability to protect against challenge with virulent virus[J].Virology,2013,443(1):99-105.
[30]Sánchez-Cordón,Pedro J,Jabbar T,Berrezaie M,Chapman D,Reis A,Sastre P,Rueda P,Goatley L,Dixon L K.Evaluation of protection induced by immunisation of domestic pigs with deletion mutant African swine fever virus BeninΔMGF by different doses and routes[J].Vaccine,2018,36(5):707-715.
[31]Reis A L,Netherton C,Dixon L K.Unraveling the armor of a killer:evasion of host defenses by African swine fever virus[J/OL].J Virol,2017,91(6):e02338-16.
[32]Reis A L,Goatley L C,Jabbar T,Sanchez-Cordon PJ,Netherton C L,Chapman D A G,Dixon L K.Deletion of the African swine fever virus gene DP148R does not reduce virus replication in culture but reduces virus virulence in pigs and induces high levels of protection against challenge[J/OL].J Virol,2017,91(24):e01428-17.
[33]Monteagudo P L,Lacasta A,López E,Bosch L,Collado J,Pina-Pedrero S,Correa-Fiz F,Accensi F,Navas M J,Vidal E,Bustos M J,Rodríguez J M,Gallei A,Nikolin V,Salas M L,Rodríguez F.BA71ΔCD2 Anew recombinant live attenuated African swine fever virus with cross-protective capabilities[J/OL].J Virol,2017,91(21):e01058-17.
[34]Escribano,JoséM,Galindo I,Alonso C.Antibody-mediated neutralization of African swine fever virus:Myths and facts[J].Virus Res,2013,173(1):101-109.
[35]Takamatsu H H,Denyer M S,Lacasta A,Stirling CM,Argilaguet J M,Netherton C L,Oura C A,Martins C,Rodríguez F.Cellular immunity in ASFV responses[J].Virus Res,2013,173(1):110-121.
[36]Neilan J G,Zsak L,Lu Z,Burrage T G,Kutish G F,Rock D L.Neutralizing antibodies to African swine fever virus proteins p30,p54,and p72 are not sufficient for antibody-mediated protection[J].Virology,2004,319(2):337-342.
[37]Argilaguet J M,Pérez-Martín E,López S,Goethe M,Escribano J M,Giesow K,Keil G M,Rodríguez F.BacMam immunization partially protects pigs against sublethal challenge with African swine fever virus.[J].Antiviral Res,2013,98(1):61-65.
[38]Lokhandwala S,Waghela S D,Bray J,Martin CL2,Sangewar N,Charendoff C,Shetti R,Ashley C,Chen C H,Berghman L R,Mwangi D,Dominowski P J,Foss D L,Rai S,Vora S,Gabbert L,Burrage T G,Brake D,Neilan J,Mwangi W.Induction of robust immune responses in swine using a cocktail of adenovirusvectored African swine fever virus antigens[J].Clin Vaccine Immunol,2016,23(11):888-900.
[39]Lokhandwala S,Waghela S D,Bray J,Sangewar N,Charendoff C,Martin C L,Hassan W S,Koynarski T,Gabbert L,Burrage T G,Brake D,Neilan J,Mwangi W.Adenovirus-vectored novel African swine fever virus antigens elicit robust immune responses in swine[J/OL].PLoS One,2017,12(5):e0177007.
[40]Gómez-Puertas P,Rodríguez F,Oviedo JM,Brun A,Alonso C,Escribano J M.The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response[J].Virology,1998,243(2):461-471.
[41]Barderas M G,Rodríguez F,Gómez-Puertas P,Avilés M,Beitia F,Alonso C,Escribano J M.Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins[J].Arch Virol,2001,146(9):1681-1691.
[42]Neilan J G,Zsak L,Lu Z,Burrage TG,Kutish G F,Rock D L.Neutralizing antibodies to African swine fever virus proteins p30,p54,and p72 are not sufficient for antibody-mediated protection[J].Virology,2004,319(2):337-342.
[43]Loperamadrid J,Osorio J E,He Y.Safety and immunogenicity of mammalian cell derived and modified vaccinia Ankara vectored African swine fever subunit antigens in swine[J].Vet Immunol Immunopathol,2017,185:20-33.
[44]Burmakina G,Malogolovkin A,Tulman E R,Zsak L,Delhon G,Diel D G,Shobogorov N M,Morgunov YP,Morgunov S Y,Kutish G F,Kolbasov D,Rock DL.African swine fever virus serotype-specific proteins are significant protective antigens for African swine fever[J].J Gen Virol,2016,97(7):1670-1675.
[45]Argilaguet J M,Pérez-Martín E,Gallardo C,Salguero F J,Borrego B,Lacasta A,Accensi F,Díaz I,Nofrarías M,Pujols J,Blanco E,Pérez-Filgueira M,Escribano J M,Rodríguez F.Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells[J].Vaccine,2011,29(33):0-5385.
[46]Argilaguet J M,Pérez-Martín E,Nofrarías M,Gallardo C,Accensi F,Lacasta A,Mora M,Ballester M,Galindo-Cardiel I,López-Soria S,Escribano J M,Reche PA,Rodríguez F.DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies[J/OL].PLoS One,2012,7(9):e40942.
[47]Lacasta A,Ballester M,Monteagudo P L,Rodríguez JM,Salas M L,Accensi F,Pina-Pedrero S,Bensaid A,Argilaguet J,López-Soria S,Hutet E,Le Potier M F,Rodríguez F.Expression library immunization can confer protection against lethal challenge with African swine fever virus[J].J Virol,2014,88(22):13322-13332.
[48]Arias M,de la Torre A,Dixon L,Gallardo C,Jori F,Laddomada A,Martins C,Parkhouse R M,Revilla Y,Rodriguez F A J,Sanchez-Vizcaino.Approaches and perspectives for development of African swine fever virus vaccines[J].Vaccines,2017,5(4):35.
基本信息:
DOI：10.13242/j.cnki.bingduxuebao.003570
中图分类号:S852.4
引用信息:
[1]李飞,徐雷,朱玲.非洲猪瘟疫苗研究进展[J].病毒学报,2019,35(04):701-707.DOI:10.13242/j.cnki.bingduxuebao.003570.
基金信息:
四川省科技计划项目(项目号:2018NZ0151);题目:非洲猪瘟综合防控技术研究~~
2019-01-23
2019
2019-04-11
2020-03-25
2020
2
2019-07-15
2019-07-15
2019-07-15